These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
9. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy. Stjernquist M Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649 [TBL] [Abstract][Full Text] [Related]
10. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog. Hutchins FL J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986 [TBL] [Abstract][Full Text] [Related]
11. Use of GnRH agonist before hysterectomy: a cost simulation. Bradham DD; Stovall TG; Thompson CD Obstet Gynecol; 1995 Mar; 85(3):401-6. PubMed ID: 7862380 [TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532 [TBL] [Abstract][Full Text] [Related]
13. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174 [TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890 [TBL] [Abstract][Full Text] [Related]
16. Major hemorrhage in a patient with multiple submucous leiomyomata during the treatment of long-acting gonadotropin-releasing hormone agonist. Wang KC; Lee WL; Yuan CC; Wang PH Kaohsiung J Med Sci; 2000 Feb; 16(2):103-7. PubMed ID: 10816995 [TBL] [Abstract][Full Text] [Related]
17. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas]. Nikolov A; Karag'ozov I Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353 [TBL] [Abstract][Full Text] [Related]
18. Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report. Thorp JM; Katz VL J Reprod Med; 1991 Aug; 36(8):625-6. PubMed ID: 1941808 [TBL] [Abstract][Full Text] [Related]
19. [Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma]. Mignemi G; Garozzo A; Livatino A; Di Leo L Minerva Ginecol; 1994 Apr; 46(4):167-72. PubMed ID: 8065589 [TBL] [Abstract][Full Text] [Related]
20. [Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period]. Russo P; Ciolli P; Atlante M; Carico E; Mancini R; Russo R; Vecchione A Minerva Ginecol; 1998 Nov; 50(11):499-502. PubMed ID: 9882992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]